Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin

• Principais autores: Leiliane Rodrigues Marcatto (Autor), Luciana Sacilotto (Autor), Letícia Camargo Tavares (Autor), Mirella Facin (Autor), Natália Olivetti (Autor), Celia Maria Cassaro Strunz (Autor), Francisco Carlos Costa Darrieux (Autor), Maurício Ibrahim Scanavacca (Autor), Jose Eduardo Krieger (Autor), Alexandre Costa Pereira (Autor), Paulo Caleb Junior Lima Santos (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2018-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Thromboembolic events are associated with high mortality and morbidity indexes. In this context, warfarin is the most widely prescribed oral anticoagulant agent for preventing and treating these events. This medication has a narrow therapeutic range and, consequently, patients usually have difficult...